European urology · 2025
Histopathology-based Artificial Intelligence Algorithms for the Prediction of Prostate Cancer Metastasis After Radical Prostatectomy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cha Eumee, Lin Zhike, Lu Jiayun, Oliveira Lia DePaula, Erak Eric, Mendes Adrianna A, Dairo Oluwademilade, Ertunc Onur, Kulac Ibrahim, Baena-Del Valle Javier A, Jones Tracy, Hicks Jessica L, Glavaris Stephanie, Guner Gunes, Vidal Igor Damasceno, Trock Bruce J, Chattopadhyay Nilanjan, Joshi Uttara, Kondragunta Chaith, Bonthu Saikiran, Han Misop, Mucci Lorelei A, Joshu Corinne, De Marzo Angelo M, Stopsack Konrad H, Singhal Nitin, Lotan Tamara L
Аннотация
BACKGROUND AND OBJECTIVE: Multimodal artificial intelligence (AI) algorithms have been validated to predict prostate cancer (PCa) metastasis using combined histopathology and clinical-pathologic parameters in clinical trial cohorts. Here, we used purely histopathology-based AI algorithms to predict the probability of lethal PCa in surgically treated population- or hospital-based cohorts, comparing with genomic classifiers and standard clinical risk tools.
METHODS: This study included representative whole slide images (WSIs) of radical prostatectomy (RP) and needle biopsy samples, or tissue microarrays (TMAs) constructed from RP specimens across five surgically treated PCa cohorts. A concatenated feature-based classification system using histopathologic data from each image generated an AI risk score for metastasis.
KEY FINDINGS AND LIMITATIONS: In Cox models for time to metastasis, an AI risk score from prostatectomy WSIs showed similar performance (C-index: 0.81-0.85) to the Decipher or Prolaris genomic classifiers (C-index: 0.72-0.80) in testing cohorts. A modified TMA AI score analyzing ∼1 mm2 of prostatectomy tumor tissue from a nationwide study of 1351 patients had a C-index of 0.71 (95% confidence interval [CI]: 0.67-0.75). In a needle biopsy cohort followed for metastasis after prostatectomy, the TMA AI score had a C-index of 0.74 (95% CI: 0.70-0.79), and models combined with the Cancer of the Prostate Risk Assessment (CAPRA) score showed improved performance (C-index: 0.83 [95% CI: 0.82-0.87]) compared with CAPRA alone (C-index: 0.79 [95% CI: 0.73-0.84]). Limitations include relatively older cohorts, with many biopsies performed before the adoption of modern magnetic resonance imaging-guided techniques.
CONCLUSIONS AND CLINICAL IMPLICATIONS: This study is among the first to show that histopathology-based AI algorithms applied to small samples of tumor tissue can predict the risk of lethal PCa. These algorithms perform comparably to commonly used genomic classifiers, and their predictive performance is enhanced when combined with clinicopathologic variables.
METHODS: This study included representative whole slide images (WSIs) of radical prostatectomy (RP) and needle biopsy samples, or tissue microarrays (TMAs) constructed from RP specimens across five surgically treated PCa cohorts. A concatenated feature-based classification system using histopathologic data from each image generated an AI risk score for metastasis.
KEY FINDINGS AND LIMITATIONS: In Cox models for time to metastasis, an AI risk score from prostatectomy WSIs showed similar performance (C-index: 0.81-0.85) to the Decipher or Prolaris genomic classifiers (C-index: 0.72-0.80) in testing cohorts. A modified TMA AI score analyzing ∼1 mm2 of prostatectomy tumor tissue from a nationwide study of 1351 patients had a C-index of 0.71 (95% confidence interval [CI]: 0.67-0.75). In a needle biopsy cohort followed for metastasis after prostatectomy, the TMA AI score had a C-index of 0.74 (95% CI: 0.70-0.79), and models combined with the Cancer of the Prostate Risk Assessment (CAPRA) score showed improved performance (C-index: 0.83 [95% CI: 0.82-0.87]) compared with CAPRA alone (C-index: 0.79 [95% CI: 0.73-0.84]). Limitations include relatively older cohorts, with many biopsies performed before the adoption of modern magnetic resonance imaging-guided techniques.
CONCLUSIONS AND CLINICAL IMPLICATIONS: This study is among the first to show that histopathology-based AI algorithms applied to small samples of tumor tissue can predict the risk of lethal PCa. These algorithms perform comparably to commonly used genomic classifiers, and their predictive performance is enhanced when combined with clinicopathologic variables.